SYT14 is a human gene whose product synaptotagmin 14 (SYT14) is a member of the synaptotagmin family, transmembrane proteins that function as calcium sensors in synaptic vesicle exocytosis and membrane trafficking. SYT14 contains two C2 domains (C2A and C2B) that bind calcium ions and mediate interactions with phospholipid membranes, enabling regulated vesicle fusion [1]. Variants in SYT14 have been implicated in Autosomal Recessive Spinocerebellar Ataxia 13 (SCAR13), Other Neurological Manifestations. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
SYT14 is a human gene whose product synaptotagmin 14 (SYT14) is a member of the synaptotagmin family, transmembrane proteins that function as calcium sensors in synaptic vesicle exocytosis and membrane trafficking. SYT14 contains two C2 domains (C2A and C2B) that bind calcium ions and mediate interactions with phospholipid membranes, enabling regulated vesicle fusion [1]. Variants in SYT14 have been implicated in Autosomal Recessive Spinocerebellar Ataxia 13 (SCAR13), Other Neurological Manifestations. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
Function
Synaptotagmin 14 (SYT14) is a member of the synaptotagmin family, transmembrane proteins that function as calcium sensors in synaptic vesicle exocytosis and membrane trafficking. SYT14 contains two C2 domains (C2A and C2B) that bind calcium ions and mediate interactions with phospholipid membranes, enabling regulated vesicle fusion [1].
Unlike the well-characterized SYT1, which triggers fast neurotransmitter release, SYT14 has distinct calcium-binding properties and may regulate slower forms of secretion or maintain synaptic vesicle pools. SYT14 is particularly important in the [cerebellum](/brain-regions/cerebellum), where it supports the function of [Purkinje cells](/cell-types/purkinje-cells) and parallel fiber synapses [2].
Key functions of SYT14 include:
Calcium-dependent regulation of vesicle exocytosis
Maintenance of synaptic vesicle pools
Membrane trafficking in cerebellar [neurons](/entities/neurons)
Biallelic loss-of-function mutations in SYT14 cause autosomal recessive spinocerebellar ataxia type 13 (SCAR13). Patients present with:
Progressive cerebellar ataxia with gait instability
Dysarthria and dysphagia
Nystagmus and oculomotor abnormalities
Variable intellectual disability
Cerebellar vermis atrophy on neuroimaging [3]
The disease mechanism involves impaired calcium-dependent vesicle release in cerebellar circuits, disrupting motor coordination and cerebellar learning.
Other Neurological Manifestations
SYT14 variants have been associated with:
Developmental delay with cerebellar signs
Action myoclonus
Seizure susceptibility in some families [4]
Expression
SYT14 shows high expression in:
Cerebellum: Purkinje cells, granule cells, and molecular layer interneurons
During development, SYT14 expression increases during postnatal cerebellar maturation, peaking during the period of synapse formation and motor circuit refinement [5].
Therapeutic Implications
Gene Therapy
For SYT14-related ataxia, AAV-mediated gene replacement targeting the cerebellum represents a potential therapeutic approach, though this remains in preclinical development.
Symptomatic Management
Current management focuses on:
Physical therapy for gait and balance
Speech therapy for dysarthria
Occupational therapy for activities of daily living
Monitoring for respiratory complications
Downstream Pathway Modulation
Enhancing residual SYT14 function or compensating through related synaptotagmin family members (e.g., SYT1, SYT2) may provide therapeutic benefit.
Related Genes and Pathways
SYT1: [Synaptotagmin 1](/genes/syt1) - fast synaptic release